Literature DB >> 12115727

CDK9 has the intrinsic property to shuttle between nucleus and cytoplasm, and enhanced expression of cyclin T1 promotes its nuclear localization.

Giuliana Napolitano1, Paolo Licciardo, Roberta Carbone, Barbara Majello, Luigi Lania.   

Abstract

CDK9 in association with cyclin T constitutes the P-TEFb complex that stimulates transcription elongation of RNAPII transcripts by phosphorylation of the CTD of RNAPII. Here we report subcellular distribution of P-TEFb in terms of localization of CDK9 and cyclin T1. We found that cyclin T1 is exclusively nuclear and it is present in nuclear-speckled structures. CDK9, albeit mainly nuclear, was also visualized in the cytoplasm. We determined that CDK9 is actively exported from the nucleus, and that leptomycin B (LMB), a specific inhibitor of nuclear export, inhibits this process. Interestingly, enforced expression of cyclin T1 enhances nuclear localization of CDK9. These findings reveal a novel control mechanism for the function of the P-TEFb complex. Copyright 2002 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12115727     DOI: 10.1002/jcp.10130

Source DB:  PubMed          Journal:  J Cell Physiol        ISSN: 0021-9541            Impact factor:   6.384


  21 in total

1.  The FCP1 phosphatase interacts with RNA polymerase II and with MEP50 a component of the methylosome complex involved in the assembly of snRNP.

Authors:  Paolo Licciardo; Stefano Amente; Luca Ruggiero; Maria Monti; Piero Pucci; Luigi Lania; Barbara Majello
Journal:  Nucleic Acids Res       Date:  2003-02-01       Impact factor: 16.971

2.  P-TEFb is not an essential elongation factor for the intronless human U2 snRNA and histone H2b genes.

Authors:  Joanne Medlin; Andrew Scurry; Alice Taylor; Fan Zhang; B Matija Peterlin; Shona Murphy
Journal:  EMBO J       Date:  2005-11-24       Impact factor: 11.598

3.  The HIV-1 Tat protein recruits a ubiquitin ligase to reorganize the 7SK snRNP for transcriptional activation.

Authors:  Tyler B Faust; Yang Li; Curtis W Bacon; Gwendolyn M Jang; Amit Weiss; Bhargavi Jayaraman; Billy W Newton; Nevan J Krogan; Iván D'Orso; Alan D Frankel
Journal:  Elife       Date:  2018-05-30       Impact factor: 8.140

4.  Computational study and peptide inhibitors design for the CDK9 - cyclin T1 complex.

Authors:  Jelena Randjelović; Slavica Erić; Vladimir Savić
Journal:  J Mol Model       Date:  2013-01-08       Impact factor: 1.810

5.  T-loop phosphorylated Cdk9 localizes to nuclear speckle domains which may serve as sites of active P-TEFb function and exchange between the Brd4 and 7SK/HEXIM1 regulatory complexes.

Authors:  Eugene C Dow; Hongbing Liu; Andrew P Rice
Journal:  J Cell Physiol       Date:  2010-07       Impact factor: 6.384

6.  Cyclin K inhibits HIV-1 gene expression and replication by interfering with cyclin-dependent kinase 9 (CDK9)-cyclin T1 interaction in Nef-dependent manner.

Authors:  Sohrab Zafar Khan; Debashis Mitra
Journal:  J Biol Chem       Date:  2011-05-09       Impact factor: 5.157

7.  The growth factor granulin interacts with cyclin T1 and modulates P-TEFb-dependent transcription.

Authors:  Mainul Hoque; Tara M Young; Chee-Gun Lee; Ginette Serrero; Michael B Mathews; Tsafi Pe'ery
Journal:  Mol Cell Biol       Date:  2003-03       Impact factor: 4.272

8.  Visualization of positive transcription elongation factor b (P-TEFb) activation in living cells.

Authors:  Koh Fujinaga; Zeping Luo; Fred Schaufele; B Matija Peterlin
Journal:  J Biol Chem       Date:  2014-12-09       Impact factor: 5.157

9.  Recruitment of cdk9 to the immediate-early viral transcriptosomes during human cytomegalovirus infection requires efficient binding to cyclin T1, a threshold level of IE2 86, and active transcription.

Authors:  Anokhi J Kapasi; Charles L Clark; Karen Tran; Deborah H Spector
Journal:  J Virol       Date:  2009-03-18       Impact factor: 5.103

10.  The human I-mfa domain-containing protein, HIC, interacts with cyclin T1 and modulates P-TEFb-dependent transcription.

Authors:  Tara M Young; Qi Wang; Tsafi Pe'ery; Michael B Mathews
Journal:  Mol Cell Biol       Date:  2003-09       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.